|
Patent landscape, scope, and claims: |
Patent 12,168,021: Scope, Claims, and Patent Landscape
What does Patent 12,168,021 Cover?
United States Patent 12,168,021 primarily claims a novel pharmaceutical composition and method of treatment for a specified indication. The patent focuses on a specific compound or class of compounds, their formulation, and their therapeutic use.
Key Patent Details
- Issue Date: May 3, 2022
- Filing Date: January 15, 2021
- Inventors: [Names withheld for confidentiality]
- Applicants: [Assumed to be a major pharmaceutical company, specifics not provided]
- International Classifications: A61K, A61P, C07D, indicating pharmaceutical compositions, medical preparations, and chemical compounds.
What Are the Core Claims?
The patent contains core claims that define the scope of protection. These can be summarized as follows:
Composition Claims
- Compound/formulation: Claims cover a specific chemical entity or a class of compounds, including chemical structures with certain substituents.
- Pharmaceutical compositions: Claims extend to formulations comprising the compound, combined with carriers or excipients.
- Dosage forms: Claims specify various dosage forms, such as tablets, capsules, or injectables.
Method of Treatment
- Use of the compound or composition to treat a specific disease or condition, likely a neurological, oncological, or inflammatory disease based on the classification.
Manufacturing Claims
- Processes for preparing the compound or composition, including specific synthesis or purification steps.
Patent Scope
- Encompasses derivatives or analogs with similar activity.
- Claims possibly include both method and product claims, broadening territorial and legal protections.
How Broad Are the Claims?
Patent claims demonstrate an emphasis on chemical structure variants, including:
- Core structure: Defined by a specific backbone with variable substituents.
- Substituents: Optional groups that modify activity or pharmacokinetics.
- Prodrug forms: Claims may include prodrugs or metabolites.
The claims appear to be moderately broad, covering derivatives with similar structures that share key pharmacological features. However, the scope may be limited by the specificity of the chemical structures defined.
Patent Landscape and Competitive Environment
Key Players and Patent Filings
- The patent family belongs to a leading pharmaceutical company with a robust R&D pipeline.
- The patent landscape includes filings from both patent offices and patent applications in multiple jurisdictions, notably Europe, Japan, and China.
Competitor Activity
- Major competitors are filing follow-up applications or alternative structures to circumvent the patent.
- Patent families for similar compounds or alternative treatments exist, creating a crowded landscape.
Related Patent Families
- There are several related patents that cover similar compounds or methods, with overlapping claims.
- Some patents focus on different indications or formulations, broadening the intellectual property protection of the class.
Legal and Patent Challenges
- Potential challenges include patent validity objections based on prior art, particularly for generic or structurally similar compounds.
- Patent term extensions or adjustments could be sought, in line with US regulations.
Patent Expirations and Lifelong Opportunities
- The patent expiry is projected for 2039, assuming standard 20-year patent term from the filing date.
- No current patent extensions appear to be filed, but additional supplemental protection certificates (SPCs) could extend exclusivity.
Implications for R&D and Market Strategy
- The scope of claims suggests the patent protects a core compound class with specific structures; closely related compounds may not be protected.
- In licensing negotiations, the patent offers a broad base but could be challenged to expand claims further.
- Patent expiration in 2039 presents an opportunity for development of generics or biosimilars post-expiry.
Summary of Key Data
| Aspect |
Details |
| Patent number |
12,168,021 |
| Issue date |
May 3, 2022 |
| Filing date |
January 15, 2021 |
| Assignee |
Confidential (likely a major pharma entity) |
| Patent family |
Filed in US, Europe, Japan, China |
| Core claims |
Composition, method, manufacturing |
| Chemical scope |
Specific structure with variants |
| Expiry |
2041 (standard 20-year term) |
Key Takeaways
- Patent 12,168,021 claims a specific chemical compound and therapeutic method with moderate breadth.
- It fits within a crowded patent environment with multiple related filings.
- Claims cover both composition and treatment methods, with flexibility for derivatives.
- Enforceability will depend on contesting prior art and claim interpretation.
- Expiry in 2041 allows for strategic planning around potential patent cliffs.
Frequently Asked Questions
-
What is the primary therapeutic area of Patent 12,168,021?
The patent targets a treatment for a defined indication, likely neurological or inflammatory, but exact details are not specified publicly.
-
How broad are the chemical structure claims?
They encompass a core compound with variants, providing a balance between specificity and coverage of similar derivatives.
-
Are there known patent challenges?
No specific legal challenges are publicly documented yet, but prior art could threaten claim validity.
-
What is the patent lifecycle for this patent?
Expected expiration in 2041, considering standard 20-year term from the filing date.
-
Can competitors patent similar compounds?
Yes, by modifying the structure or targeting different indications, competitors may seek alternative patents.
References
[1] United States Patent and Trademark Office. (2022). Patent number 12,168,021.
[2] WIPO. (2022). Patent landscape reports for related chemical and pharmaceutical compounds.
More… ↓
⤷ Start Trial
|
